News

Schwab U.S. Dividend Equity ETF is a popular dividend-focused ETF. Read why SCHD's slump makes it a more interesting time to ...
The biggest deals in the Payer sector are made at Becker’s Healthcare events Forge powerful, in-person connections with senior leaders from across the Payer industry. At Becker’s Payer Issues ...
Qure's long-term success hinges on overcoming regulatory and logistical challenges. See why I rate QURE stock a hold.
EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...
The event will run from 9 a.m. to 3 p.m. at three barbershops on Franklin Street: Central at Sharper's Image inside Meijer N & Out Platinum Designs Health education and giveaways will also take place.
What’s Next: Shaping a More Resilient Future As the healthcare industry continues to digitize and evolve, Performant is committed to equipping payers, providers and government agencies with the ...
Hawaii hospitals are reporting a backlog of thousands of images needing to be interpreted by radiologists, Hawaii News Now reported April 18. The state is estimated to have a shortage of 10 ...
The idea of a government-run, single payer healthcare system While centralising a healthcare system is a monumental job, it has been done in some Nordic countries with varying levels of success ...
The healthcare giant also slashed its 2025 earnings outlook, causing its shares to plunge 23% on Thursday. Rising care intensity and shifting reimbursement policies impacted the company's ...
Healthcare had another busy week. Here’s some of our top analyses to help you make sense of it all. Senate GOP accidentally makes ACA subsidy extension 'free' Senate Republicans have a bright ...
And, if the Department of Health and Human Services (HHS) secretary, in this case Robert F. Kennedy Jr., wants to replace all committee members until the task force is comprised of members that ...
Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures ...